SCHEMBL7697393

SCHEMBL7697393

O=C(NCc1ccc(F)cc1)[C@H]1CC[C@H](Cc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.51
ALDH1A1 P00352 3/20 0.49
TSHR P16473 1/20 0.49
IDO1 P14902 1/20 0.49
HTT P42858 2/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
PKM P14618 1/20 0.48
POLB P06746 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FPR3 P25089 1/20 0.47
FPR2 P25090 1/20 0.47
TP53 P04637 1/20 0.47
GRIN2B Q13224 1/20 0.47
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7693251 1.00 MEN1 (0.53) MEN1KMT2ALMNAALDH1A1TSHR
SCHEMBL7692347 1.00 MEN1 (0.53) MEN1KMT2ALMNAALDH1A1TSHR
SCHEMBL7682709 0.91 IDO1 (0.56) ALDH1A1IDO1GAAPKMSMN1; SMN2
SCHEMBL7083207 0.91 IDO1 (0.56) ALDH1A1IDO1GAAPKMSMN1; SMN2
SCHEMBL7083210 0.91 IDO1 (0.56) ALDH1A1IDO1GAAPKMSMN1; SMN2
SCHEMBL7692588 0.90 LMNA (0.54) MEN1KMT2ALMNAIDO1PKM
SCHEMBL7695913 0.90 LMNA (0.54) MEN1KMT2ALMNAIDO1PKM
SCHEMBL7697154 0.90 LMNA (0.54) MEN1KMT2ALMNAIDO1PKM
SCHEMBL7696051 0.89 IDO1 (0.49) IDO1KDM4EPKMSMN1; SMN2FPR3
SCHEMBL7691314 0.89 NPC1 (0.55) KMT2AIDO1PKMPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6495561-B2 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2002-12-17 US disclosed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed